Jazz Pharmaceuticals plc Effective Tax Rate
Jazz Pharmaceuticals plc (JAZZ) reported Effective Tax Rate of 43.40% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-02-24
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, percent for the quarter ending 2021-03-31 was 13.30%, a 45.71% decline year-over-year.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, percent for the quarter ending 2020-09-30 was 11.50%, a 21.05% increase year-over-year.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, percent for the quarter ending 2020-06-30 was 31.90%.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, percent for the quarter ending 2020-03-31 was 24.50%, a 3.16% decline year-over-year.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, percent for fiscal 2025 was 43.40%.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, percent for fiscal 2021 was -191.50%, a 1669.67% decline from fiscal 2020.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, percent for fiscal 2020 was 12.20%.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, percent for fiscal 2019 was -16.10%, a 206.62% decline from fiscal 2018.
pure
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 9 month as first filed | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | 43.40% 10-K · filed 2026-02-24 | ||||||
| 2021-12-31 | -191.50% 10-K · filed 2022-03-01 | ||||||
| 2021-03-31 | 13.30% 10-Q · filed 2021-05-04 | ||||||
| 2020-12-31 | 12.20% 10-K · filed 2022-03-01 | ||||||
| 2020-09-30 | 11.50% 10-Q · filed 2020-11-02 | 17.50% 10-Q · filed 2020-11-02 | |||||
| 2020-06-30 | 31.90% 10-Q · filed 2021-08-03 | -9.20% 10-Q · filed 2021-08-03 | |||||
| 2020-03-31 | 24.50% 10-Q · filed 2021-05-04 | ||||||
| 2019-12-31 | -16.10% 10-K · filed 2022-03-01 | ||||||
| 2019-09-30 | 9.50% 10-Q · filed 2020-11-02 | -9.30% 10-Q · filed 2020-11-02 | |||||
| 2019-06-30 | -42.70% 10-Q · filed 2020-08-04 | -16.50% 10-Q · filed 2020-08-04 | |||||
| 2019-03-31 | 25.30% 10-Q · filed 2020-05-05 | ||||||
| 2018-12-31 | 15.10% 10-K · filed 2021-02-23 | ||||||
| 2018-09-30 | 11.40% 10-Q · filed 2019-11-05 | 20.60% 10-Q · filed 2019-11-05 | |||||
| 2018-06-30 | 28.20% 10-Q · filed 2019-08-06 | 28.60% 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | 29.20% 10-Q · filed 2019-05-07 | ||||||
| 2017-12-31 | -10.80% 10-K · filed 2020-02-25 | ||||||
| 2017-09-30 | 1.90% 10-Q · filed 2018-11-06 | 20.50% 10-Q · filed 2018-11-06 | |||||
| 2017-06-30 | 25.10% 10-Q · filed 2018-08-07 | 25.20% 10-Q · filed 2018-08-07 | |||||
| 2017-03-31 | 25.20% 10-Q · filed 2018-05-08 | ||||||
| 2016-12-31 | 25.40% 10-K · filed 2019-02-26 | ||||||
| 2016-09-30 | 22.70% 10-Q · filed 2017-11-07 | 25.00% 10-Q · filed 2016-11-08 | 26.50% 10-Q · filed 2017-11-07 | 28.50% 10-Q · filed 2016-11-08 | |||
| 2016-06-30 | 26.90% 10-Q · filed 2017-08-08 | 28.90% 10-Q · filed 2016-08-09 | 28.10% 10-Q · filed 2017-08-08 | 30.00% 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | 29.90% 10-Q · filed 2017-05-09 | 31.50% 10-Q · filed 2016-05-10 | |||||
| 2015-12-31 | 24.40% 10-K · filed 2018-02-27 | ||||||
| 2015-09-30 | 25.40% 10-Q · filed 2016-11-08 | 27.30% 10-Q · filed 2016-11-08 | |||||
| 2015-06-30 | 25.80% 10-Q · filed 2016-08-09 | 28.30% 10-Q · filed 2016-08-09 | |||||
| 2015-03-31 | 31.20% 10-Q · filed 2016-05-10 | ||||||
| 2014-12-31 | 62.20% 10-K · filed 2017-02-28 | ||||||
| 2014-09-30 | 48.50% 10-Q · filed 2014-11-04 | 166.90% 10-Q · filed 2014-11-04 | |||||
| 2014-06-30 | 30.70% 10-Q · filed 2015-08-05 | 32.10% 10-Q · filed 2014-08-05 | |||||
| 2014-03-31 | 33.80% 10-Q · filed 2015-05-07 | ||||||
| 2013-12-31 | 29.80% 10-K · filed 2016-02-23 | ||||||
| 2013-09-30 | 19.60% 10-Q · filed 2014-11-04 | 27.00% 10-Q · filed 2014-11-04 | |||||
| 2013-06-30 | 35.90% 10-Q · filed 2014-08-05 | 32.50% 10-Q · filed 2014-08-05 | |||||
| 2013-03-31 | 28.90% 10-Q · filed 2014-05-08 | ||||||
| 2012-12-31 | -47.20% 10-K · filed 2015-02-24 | ||||||
| 2012-09-30 | 27.70% 10-Q · filed 2013-11-05 | 20.80% 10-Q · filed 2013-11-05 | |||||
| 2012-06-30 | 17.50% 10-Q · filed 2013-08-06 | 19.50% 10-Q · filed 2012-08-07 | 16.50% 10-Q · filed 2013-08-06 | 18.10% 10-Q · filed 2012-08-07 | |||
| 2012-03-31 | 15.40% 10-Q · filed 2013-05-07 | 16.60% 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | 0.00% 10-K · filed 2014-02-25 | ||||||
| 2011-09-30 | 0.00% 10-Q · filed 2012-11-09 | 0.00% 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | 0.00% 10-Q · filed 2012-08-07 | 0.00% 10-Q · filed 2012-08-07 | |||||
| 2010-12-31 | 0.00% 10-K · filed 2013-02-26 |
Rate
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month |
|---|---|---|---|
| 2023-09-30 | -0.47 Rate 10-Q · filed 2023-11-08 | -0.37 Rate 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -0.30 Rate 10-Q · filed 2023-08-09 | -0.29 Rate 10-Q · filed 2023-08-09 | |
| 2022-09-30 | 0.72 Rate 10-Q · filed 2023-11-08 | 1.79 Rate 10-Q · filed 2023-11-08 | |
| 2022-06-30 | -0.77 Rate 10-Q · filed 2023-08-09 | -0.57 Rate 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |